Language selection

Government of Canada / Gouvernement du Canada

Search

Details on Transfer Payment Programs

Table of Contents

Transfer payment programs with total planned spending of $5 million or more

Canada Brain Research Fund Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Canada Brain Research Fund Program is to catalyze private and charitable funding to support brain research and accelerate discoveries to improve the health and quality of life for Canadians who are at risk of or affected by brain diseases/disorders.

The Government of Canada's objectives in funding Brain Canada, the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: Brain Canada is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 3: Quality Health Science, Data and Evidence

Expected results

In 2026-27, Brain Canada will continue to:

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 28,393,089 30,000,000 15,000,000 0
Total other types of transfer payments 0 0 0 0
Total program 28,393,089 30,000,000 15,000,000 0

Canadian Thalidomide Survivors Support Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Canadian Thalidomide Survivors Support Program is to contribute to meeting the needs of thalidomide survivors so that they may age with dignity.

The objectives of this Program are to ensure that, for the remainder of their lives, eligible thalidomide survivors:

Recipients

General targeted recipients groups: Canadian not-for-profit and for-profit organizations. Epiq Class Action Services Canada Inc. is the sole recipient until 2029-30.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 2: Healthy People and Communities

Expected results

In 2026-27, the recipient, Epiq Class Action Services Canada Inc., will continue to engage directly with recognized thalidomide survivors through an annual survey to better understand their evolving needs. Based on survivor feedback and regular meetings with the Thalidomide Victims Association of Canada, the recipient will actively enhance processes to support survivors and will continue to increase awareness and access to available supports.

Expected results are that thalidomide survivors will access care, treatment and/or support which in turn will contribute to their aging with dignity.

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 15,085,800 15,387,516 15,695,266 16,009,171
Total other types of transfer payments 0 0 0 0
Total program 15,085,800 15,387,516 15,695,266 16,009,171

Climate Change and Health Capacity Building Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Climate Change and Health Capacity Building Program is to support efforts to build climate-resilient and low-carbon health systems and protect and improve the health of people living in Canada in a changing climate, including from extreme heat, through better understanding of risks and successful adaptation options, and building capacity to address and implement them.

The objectives of this Program are to:

The Program has two streams: HealthADAPT and HeatADAPT.

Recipients

General targeted recipients groups: Not-for-profit organizations; academia and public institutions; Indigenous recipients; government; international; for-profit organizations; and others such as professional associations and social services organizations.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 11: Climate Change

Expected results

In 2026-27, expected results include increased actions to:

These expected results will be measured by:

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 5,396,290 5,256,290 5,930,435 0
Total other types of transfer payments 0 0 0 0
Total program 5,396,290 5,256,290 5,930,435 0

Contribution to Canada Health Infoway

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Contribution to Canada Health Infoway (Infoway) Program is to accelerate the development and adoption of digital health technologies, underpinned by pan-Canadian standards, as a driver for health innovation and for health system transformation, in order to improve access, increase efficiency and improve health outcomes for Canadians.

The Government of Canada's objective in funding Infoway, the sole recipient of this Program, is to advance collaboration with provinces and territories and other stakeholders on digital health innovation, in addressing gaps and strategic opportunities to strengthen the health information infrastructure, ensuring Canada's health care system is modernized, connected, accessible, and innovative.

Recipients

General targeted recipients groups: Infoway is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In 2026-27, Infoway will continue leading pan-Canadian efforts to make Canada's digital health information systems work better together. By advancing the Shared Pan-Canadian Interoperability Roadmap, Infoway will help governments and health information technology vendors to adopt common standards so health information can move securely and easily between care settings, and provinces, and territories. Ultimately, these efforts will enable Canadians to access their health information in a secure digital format, and improve health care through the availability of reliable and timely health data. Infoway's key activities will include:

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 67,314,500 52,000,000 52,000,000 52,000,000
Total other types of transfer payments 0 0 0 0
Total program 67,314,500 52,000,000 52,000,000 52,000,000

Contribution to Canada's Drug AgencyFootnote 1

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Contribution to Canada's Drug Agency Program is to enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.

The Government of Canada's objectives in funding Canada's Drug Agency - L'Agence des médicaments du Canada (CDA-AMC) (formerly known as the Canadian Agency for Drugs and Technologies in Health), the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: CDA-AMC is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In 2026-27, the CDA-AMC is expected to continue delivering credible, objective evidence-informed drug and health technology decisions for Canada. Through developing and disseminating knowledge products, and establishing collaborative networks, and partnerships, funding to CDA-AMC will:

Funding to CDA-AMC will also continue to support the implementation of the National Strategy for Drugs for Rare Diseases which will improve the collection and use of real-world evidence on drugs for rare diseases including patient registries to support decision-makers and clinicians.

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 59,545,678 60,182,678 50,799,678 49,916,978
Total other types of transfer payments 0 0 0 0
Total program 59,545,678 60,182,678 50,799,678 49,916,978

Contribution to Improve Health Care Quality and Patient Safety

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Contribution to Improve Health Care Quality and Patient Safety Program is to improve the quality of health care services by strengthening system coordination related to patient safety and foster innovations in health care to help advance the delivery of high-quality care and to increase efficiency in the health system.

The Government of Canada's objectives in funding Healthcare Excellence Canada (HEC), the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: Healthcare Excellence Canada is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 2: Healthy People and Communities

Expected results

In the short-term, HEC's work will contribute to spreading promising innovations, sustaining meaningful relationships with people HEC works with, catalyzing policy change, and assisting in preparing health leaders to lead improvement efforts.

In the medium-term, HEC's work will contribute to assisting the settings represented by the intermediaries HEC reaches (e.g., long-term care facilities, primary care facilities) in employing evidence-informed practices; and implementing policy changes to catalyze health quality and patient safety improvement and developing cultures conducive to improvement. Ultimately, HEC's work will contribute to sustaining, spreading, and scaling improvements as well as assisting health care settings in providing high-quality, safe, patient-oriented, and culturally safe care.

In 2026-27, HEC will continue to advance priorities such as:

HEC will also explore ways to support innovation in primary care, including a focus on how interdisciplinary team-based care can improve timely access to primary care and reduce strain on the health care system.

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 24,600,000 24,600,000 24,600,000 24,600,000
Total other types of transfer payments 0 0 0 0
Total program 24,600,000 24,600,000 24,600,000 24,600,000

Contribution to the Canadian Institute for Health Information

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Contribution to the Canadian Institute for Health Information Program (CIHI) is to support the development of a national health information system in order to achieve nationally comparable information for measuring wait times and outcomes of care, determine the relative effectiveness of policies or investments, and build a coordinated approach to health information in Canada that will address gaps in the knowledge base and provide the information needed to assess the health of Canadians and the health system.

The Government of Canada's objectives in funding CIHI, the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: Canadian Institute for Health Information is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 3: Quality Health Science, Data and Evidence

Expected results

In 2026-27, CIHI will continue to address data gaps in priority areas across the continuum of health care, including primary care, home and community care, long-term care, mental health care and addictions, pharmaceuticals, and physician billing virtual care. Specific activities include:

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 127,158,979 150,958,979 150,158,979 95,658,979
Total other types of transfer payments 0 0 0 0
Total program 127,158,979 150,958,979 150,158,979 95,658,979

Contribution to the Canadian Partnership Against Cancer

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Contribution to the Canadian Partnership Against Cancer (CPAC) Program is to support the continued implementation of the Canadian Strategy for Cancer Control (the Strategy) and progress toward the Strategy's long-term outcomes:

CPAC is fully funded by the Government of Canada, with Budget 2016 confirming ongoing funding at $47.5 million per year.

The Government of Canada's objective in funding CPAC, the sole recipient of this Program, is to maximize the translation, transfer, and sharing of knowledge across Canada's cancer system to reduce fragmentation in cancer knowledge and service delivery and make measurable improvements in the health of Canadians.

Recipients

General targeted recipients groups: Canadian Partnership Against Cancer is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In 2026-27, CPAC will continue driving system-wide changes, working closely with its funded partners, to advance the goals of the Canadian Strategy for Cancer Control. Activities include:

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 47,500,000 47,500,000 47,500,000 47,500,000
Total other types of transfer payments 0 0 0 0
Total program 47,500,000 47,500,000 47,500,000 47,500,000

Diabetes Devices and Supplies Fund

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Diabetes Devices and Supplies Fund is to increase access to diabetes devices and supplies to better manage the condition and improve health outcomes.

The objective of the initiative is to provide funding through bilateral funding agreements to provincial and territorial governments so they can support access to devices and supplies that people with diabetes require to manage their condition (e.g., insulin pumps, glucose monitors, syringes and glucose test strips) for their residents.

Recipients

General targeted recipients groups: Provincial and territorial governments.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In the short-term, provinces and territories are engaged in implementing initiatives to support access to diabetes devices and supplies. The number of provinces and territories implementing initiatives will indicate where and how much access has increased.

In the medium-term, residents of provinces and territories with bilateral funding agreements have increased access to diabetes devices and supplies, through reduced out-of-pocket costs as indicated by total out-of-pocket cost savings to residents.

Evaluation

Fiscal year of next planned evaluation: 2029-30

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 20,487,407 37,839,549 0 0
Total other types of transfer payments 0 0 0 0
Total program 20,487,407 37,839,549 0 0

Health Care Policy and Strategies Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Health Care Policy and Strategies Program is to support the federal government's commitment to maintain a strong and effective publicly funded health care system through investments in emerging and demonstrated innovations in priority areas such as palliative and end-of-life care, home and community care, mental health care and other federal, provincial, territorial, and emerging priorities.

The objectives of this Program are to:

The Program's authorities also support funding to various federal initiatives such as for palliative care and medical assistance in dying (including funding for implementing the Department's Action Plan on Palliative Care) (2021), Health Workforce Canada (2023), the Sexual and Reproductive Health Fund (2024), the Youth Mental Health Fund (2024), efforts to effectively integrate internationally educated health professionals into Canada's health workforce (2024), Canada's Black Justice Strategy (2025), and the Terry Fox Research Institute (2025).

Recipients

General targeted recipients groups: Non-profit non-governmental organizations, and other levels of government (provincial, territorial, and local).

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Expected results

In 2026-27, Program funding will support a wide range of projects designed to ultimately contribute to improvements in the accessibility, quality, sustainability, and accountability of the health care system. These improvements could ultimately benefit either specific populations, or all Canadians. Key priorities include projects that will:

Evaluation

Fiscal year of next planned evaluation: 2028-29

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 180,086,612 137,210,646 169,657,671 158,922,228
Total other types of transfer payments 0 0 0 0
Total program 180,086,612 137,210,646 169,657,671 158,922,228

Mental Health Commission of Canada Contribution Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Mental Health Commission of Canada (MHCC) Contribution Program is to promote mental health in Canada and foster change in the delivery of mental health services, including substance use and suicide prevention.

The Government of Canada's objectives in funding the MHCC, the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: The Mental Health Commission of Canada is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 2: Healthy People and Communities

Expected results

On January 15, 2026, MHCC's contribution agreement was extended for an additional year until March 31, 2027.

The MHCC is expected to contribute to the improved mental health and well-being of Canadians, notably in the areas of suicide prevention, stigma reduction, population-based initiatives, and mental health and substance use integration. This will be done through developing and disseminating knowledge products, establishing collaborative partnerships, and providing evidence-based training.

In 2026-27, the MHCC will:

Evaluation

Fiscal year of next planned evaluation: 2028-29

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 14,250,000 14,250,000 0 0
Total other types of transfer payments 0 0 0 0
Total program 14,250,000 14,250,000 0 0

National Strategy for Drugs for Rare Diseases Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the National Strategy for Drugs for Rare Diseases Program is to provide funding to willing jurisdictions to improve access for patients to drugs for rare diseases (DRD), as well as improving and broadening rare disease treatments and services, in order to achieve better health outcomes.

The objectives of this Program are to:

Recipients

General targeted recipients groups: Provincial and territorial governments.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Healthcare Systems

Expected results

In 2026-27, expected results include enhanced collaboration among public drug plans to ensure consistent patient access. Over time, this work is expected to lead to improved health and better access to health care for Canadians with rare diseases by:

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 472,933,889 472,933,889 0 0
Total other types of transfer payments 0 0 0 0
Total program 472,933,889 472,933,889 0 0

Note: These amounts will be allocated to provinces and territories using funding approaches outlined in bilateral agreements in combination with a per capita basis based on population estimates from Statistics Canada.

Official Languages Health Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Official Languages Health Program is to enhance access to health services for official language minority communities (OLMCs) through investments to support the active offer of services in the minority official language for OLMCs in priority areas such as, but not limited to primary care, home care, mental health, and palliative care and end-of-life care.

The objectives of this Program are to:

Recipients

General targeted recipients groups: Non-profit entities, provincially-accredited postsecondary institutions, and provincial and territorial governments.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 2: Healthy People and Communities

Expected results

In 2026-27, Program funding will support:

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 40,624,999 40,625,000 40,625,000 37,400,000
Total other types of transfer payments 0 0 0 0
Total program 40,624,999 40,625,000 40,625,000 37,400,000

Oral Health Access Fund

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Oral Health Access Fund (OHAF) is to provide funding to selected projects that will undertake actions to reduce or remove barriers to accessing oral health care for targeted populations.

OHAF's target populations include but are not limited to children, Indigenous Peoples, newcomers to Canada, official language minority communities, people who experience homelessness, persons with disabilities, rural and remote communities, and seniors. Budget 2023 announced $250 million over 3 years, starting in 2025-26, and $75 million ongoing to establish OHAF.

The objectives are to:

Recipients

General targeted recipients groups: Eligible recipients include Canadian oral health training institutions, not-for-profit organizations, for-profit organizations, other levels of government and their agencies, such as provinces, territories, Indigenous governing bodies, and municipalities.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 4: Oral Health

Expected results

In 2026-27, expected results will include improved access to funding to support training and provider capacity, connect more people to care, and support prevention and education efforts aimed at improving oral health for the target population..

Selected projects will support the advancement of OHAF's outcomes of reducing or removing barriers to accessing oral health care.

Evaluation

Fiscal year of next planned evaluation: 2029-30

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 18,750,000 0 0 0
Total contributions 31,250,000 33,892,780 21,809,632 9,750,359
Total other types of transfer payments 0 0 0 0
Total program 50,000,000 33,892,780 21,809,632 9,750,359

Organs, Tissues, and Blood Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Organs, Tissues, and Blood Program is to support safe, effective, accessible, and responsive organ, tissue and blood systems. This will improve and extend the quality of the lives of Canadians while respecting the federal role and interests.

The Government of Canada's objectives in funding Canadian Blood Services (CBS), the sole recipient of this Program, are to:

Recipients

General targeted recipients groups: Canadian Blood Services is the sole recipient.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Expected results

In 2026-27, CBS is expected to:

Various stakeholders, including Health Canada, use the knowledge generated by organ and tissue donation and transplantation projects and blood research and development projects to inform changes to practices and standards. This will contribute to greater safety, effectiveness, accessibility and responsiveness of the organ, tissue and blood systems to improve and extend the quality of lives of Canadians.

Organ and Tissue Donation and Transplantation

CBS will work with partners and stakeholders to influence and improve system performance through development and dissemination of leading practices, professional and public education, engagement, and awareness materials. CBS is Co-Chair and Secretariat for the System Operators Advisory Committee under the Pan-Canadian Organ Donation and Transplantation Governance Structure and will continue, as the national coordination agency, to focus on the priorities identified by the new governance body to improve organ and tissue donation and transplantation.

Blood Research and Development

In this context, "blood" includes whole blood and blood products, plasma and plasma products and their respective artificial and substitute products.

CBS will help maintain and increase the safety, supply, and efficiency of the Canadian blood system by advancing innovation and maintaining Canadian capacity in transfusion science and medicine. In 2026-27, CBS is expected to continue to foster research, facilitate dissemination and application of knowledge, educate the next generation of scientific and health care experts, and engage with an interdisciplinary network of partners in Canada and beyond.

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 8,980,000 8,580,000 8,580,000 8,580,000
Total other types of transfer payments 0 0 0 0
Total program 8,980,000 8,580,000 8,580,000 8,580,000

Substance Use and Addictions Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: Health Canada's Substance Use and Addictions Program (SUAP) provides contribution funding to address substance use issues. This funding is provided to other levels of government, community-led and not-for-profit organizations in Canada for a wide range of innovative and evidence-informed substance use prevention, harm reduction and treatment initiatives. These include public education, capacity building, research, best practices, standards and service delivery initiatives that target a range of substances, including opioids, stimulants, cannabis, alcohol, tobacco, and vaping products.

In addition, SUAP provides targeted contribution funding through the Emergency Treatment Fund to municipalities and Indigenous communities, enabling them to respond quickly to urgent and critical needs related to substance use and the illegal drug crisis. These initiatives are designed to complement and enhance existing federal, provincial, and territorial investments.

Recipients

General targeted recipients groups: Community-based, Indigenous, regional and national non-profit organizations, including the health and education sectors; and other levels of government and their agencies.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Expected results

Health Canada provides contribution funding through SUAP in support of the Canadian Drugs and Substance Strategy, Canada's Black Justice Strategy, as well as the delivery of 3 of the department's programs: Tobacco Control, Controlled Substances, and Cannabis. Budget 2023 committed $144 million to SUAP supporting the creation of 75 projects from the 2023 call for proposals. These projects are all ongoing and will continue through fiscal year 2026-27.

Budget 2024 committed an additional $150 million over 3 years to establish an Emergency Treatment Fund (ETF) as part of SUAP. The ETF provides short-term contribution funding to First Nations, Inuit and Métis communities, as well as municipalities, to help address urgent needs related to the rising harms and deaths from the illegal drug crisis. This funding complements Provincial/Territorial and Indigenous efforts, ensuring funds are directed to high-need communities, and reinforcing links to federal commitments on the drug crisis. New and some existing projects will continue to be funded in 2026-27.

It is expected that through these investments, Canadians and stakeholders will have:

In the longer-term, this will lead to improved knowledge that will help Canadians make informed decisions about their health to reduce risk-taking behavior and the negative health impacts experienced by people who use drugs.

Evaluation

Fiscal year of next planned evaluation

2030-31 – Evaluation of the Health Portfolio's Tobacco and Vaping Activities

2027-28 – Evaluation of the Legalization and Regulation of Cannabis

2027-28 – Horizontal Evaluation of the Canadian Drugs and Substances Strategy

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 157,713,930 122,143,220 66,847,971 36,560,774
Total other types of transfer payments 0 0 0 0
Total program 157,713,930 122,143,220 66,847,971 36,560,774

Territorial Health Investment Fund

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Territorial Health Investment Fund (THIF) aligns with the Government of Canada's commitment to reconciliation with Indigenous Peoples. Since Indigenous Peoples make up a significant proportion of the population in the territories, investments to support enhanced access to health services will contribute to closing the gap in health status between Indigenous populations and other Canadians.

The objective of this Fund is to support territorial governments' efforts to innovate and transform their health care systems and ensure Northerners have access to the health care they need.

Recipients

General targeted recipients groups: Territories.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

The THIF will continue to support territorial efforts to innovate and transform their health care systems and ensure Northerners have access to the health care they need. The expected results for residents in the territories include:

Evaluation

Fiscal year of next planned evaluation: 2027-28

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 35,000,000 35,000,000 35,000,000 35,000,000
Total contributions 0 0 0 0
Total other types of transfer payments 0 0 0 0
Total program 35,000,000 35,000,000 35,000,000 35,000,000

The Shared Health Priorities Initiative

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Shared Health Priorities Initiative Program is to provide funding to provinces and territories through bilateral funding agreements to target:

The objective of this Program is to provide supports that build on and enhance provincial and territorial efforts, and capacity in targeted areas to strengthen and help build health care systems.

Recipients

General targeted recipients groups: Provinces and territories.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In 2026-27, it is expected that through these investments, Canadians will experience:

Working Together Bilateral agreements signed with provinces and territories in 2023-24, provide the first three years of the $25 billion investment over 10 years, plus remaining Budget 2017 funding for mental health and substance use ($2.4 billion). Aging with Dignity bilateral agreements also signed with provinces and territories in 2023-24, provide $5.4 billion over five years in remaining Budget 2017 funding for home and community care and Budget 2021 funding for long-term care.

Health Canada is working with provinces and territories on the renewal of the Working Together bilateral agreements to continue advancing the shared health priorities. As part of these agreements, provincial and territorial governments will develop action plans outlining how funding would be allocated to each priority area and identifying indicators and targets to measure progress. Provinces and territories report annually on progress towards these targets to their residents. Signs of progress will include growth in the number of health professionals, greater availability of integrated youth mental health services, and a higher number of surgeries completed than pre-pandemic levels.

Federal funding of $15 million provided to Ontario in 2025-26 will support Runnymede First Responders Post-Traumatic Stress Injury (PTSI) Rehabilitation Centre of Excellence. This funding will bolster access to quality mental health and substance use services beyond the Working Together bilateral agreements, resulting in a dedicated PTSI assessment and outpatient treatment centre for frontline health workers, first responders and public safety personnel, as well as a dedicated residential treatment facility.

Federal funding of $60 million provided to New Brunswick in 2025-26 will support bilingual health technology and clinical information systems for effective health service delivery. This funding will bolster health system modernization improvements beyond the Working Together bilateral agreements, resulting in improved data quality and health care system coordination and higher quality care for the population of New Brunswick.

Evaluation

Fiscal year of next planned evaluation: Not applicable, this initiative is a transfer of funds to the provinces and territories. Furthermore, as per the various funding agreements, the provinces and territories have committed to conducting evaluations to demonstrate the impact of this funding.

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 0 0 0 0
Total other types of transfer payments 4,426,329,271 4,642,310,000 3,450,000,000 2,859,000,000
Total program 4,426,329,271 4,642,310,000 3,450,000,000 2,859,000,000

Note: These amounts will be allocated to provinces and territories using funding approaches outlined in bilateral agreements in combination with a per capita basis based on population estimates from Statistics Canada.

Universal Access to Contraception and Diabetes Medications Initiative

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Universal Access to Contraception and Diabetes initiative is to provide universal, single-payer, first-dollar coverage for a range of contraception and diabetes prescription drugs and related products to improve health outcomes.

The objective of the initiative is to provide funding through bilateral funding agreements to provincial and territorial governments so they can improve residents' access to contraception and diabetes prescription drugs and related products and enable residents to better manage their health conditions.

Recipients

General targeted recipients groups: Provincial and territorial governments.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Expected results

In the short-term (1-2 years), an increase in residents accessing a range of diabetes and contraception drugs and devices through provincial and territorial public drug plans is expected. The number of jurisdictions implementing universal, single-payer, first-dollar coverage for a range of contraception and diabetes prescription drugs and related products will indicate where and how much access has increased.

In the medium-term (2-5 years), an increase in the number of Canadians taking their contraception and diabetes medications as prescribed is expected. This will be measured using Statistics Canada data on reporting cost-related non-adherence (not taking diabetes or contraception prescriptions for reasons related to cost).

Evaluation

Fiscal year of next planned evaluation: 2029-30

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 0 0 0 0
Total other types of transfer payments 100,939,163 320,066,361 477,227,188 477,227,188
Total program 100,939,163 320,066,361 477,227,188 477,227,188

Transfer payment programs with total planned spending of less than $5 million

Chemicals Management Plan Engagement and Outreach Contribution Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Chemicals Management Plan Engagement and Outreach Contribution Program is to support the capacity of people in Canada, with an emphasis on populations who may be disproportionately impacted and Indigenous Peoples, to engage in the Chemicals Management Plan and environmental health programs, allowing for a broad range of expertise and opinions to be heard and considered. This Program also supports partnerships to increase outreach to Canadians about environmental health issues, using tailored tools and messaging. This includes raising awareness of the impacts of chemicals on human health and how to reduce the risks. The Program's authorities also support initiatives related to the National Framework on Cancers Linked to Firefighting.

Recipients

General targeted recipients groups: For-profit organizations; not-for-profit organizations and charities; academia and public institutions; Indigenous recipients; government; individuals; health service organizations, including Indigenous health organizations and community health centres.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 13: Health Impacts of Chemicals

Expected results

The expected result is:

This expected result will be measured by the following indicator:

Evaluation

Fiscal year of next planned evaluation: 2028-29

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 1,305,000 885,000 830,000 680,000
Total other types of transfer payments 0 0 0 0
Total program 1,305,000 885,000 830,000 680,000

Environmental Health Research Contribution Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Environmental Health Research Contribution Program is to build external capacity and research infrastructure by funding research activities on environmental pollutants, including microplastics, to improve the health and quality of life of people in Canada. A specific Microplastics stream was established to fund research to better understand the potential impact of microplastics on human health, strengthen domestic research capacity, and build evidence to help drive decision-making.

Recipients

General targeted recipients groups: Not-for-profit organizations; academia and public institutions; government; and professional associations.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 13: Health Impacts of Chemicals

Expected results

The expected result is:

This expected results will be measured by the following indicator:

Evaluation

Fiscal year of next planned evaluation: 2026-27

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 538,580 538,580 0 0
Total other types of transfer payments 0 0 0 0
Total program 538,580 538,580 0 0

Radon Outreach Contribution Program

Timeframe of the transfer payment program

Funding details

Purpose and objectives

Purpose and objectives of transfer payment program: The purpose of the Radon Outreach Contribution Program is to protect and improve human health and well-being in Canada from the impacts of indoor radon exposure, by aiding in the education of people in Canada about the importance of testing their homes, schools, and workplaces for radon and reducing radon levels where necessary.

Recipients

General targeted recipients groups: Not-for-profit organizations and charities; academia and public institutions; Indigenous recipients; government; and professional associations.

Departmental results framework

Link to the departmental result(s)

Link to the department's Program inventory

Program 19: Radiation Protection

Expected results

The expected results are:

These expected results will be measured by the following indicators:

Evaluation

Fiscal year of next planned evaluation: 2030-31

Financial information (dollars)
Type of transfer payment 2025–26
Forecast spending		 2026–27
Planned spending		 2027–28
Planned spending		 2028–29
Planned spending
Total grants 0 0 0 0
Total contributions 350,000 250,000 250,000 250,000
Total other types of transfer payments 0 0 0 0
Total program 350,000 250,000 250,000 250,000

Footnote

Footnote 1

Legal name is Canadian Agency for Drugs and Technologies in Health and is operating as "Canada's Drug Agency".

Return to footnote 1 referrer

Footnote 2

guidance activities include the development of a guidance document, as well as knowledge translation products that can include but are not limited to training sessions and journal articles for health care providers.

Return to footnote 2 referrer

Page details

2026-03-13